Search for: "Wyeth Pharmaceuticals"
Results 521 - 540
of 976
Sort by Relevance
|
Sort by Date
2 Feb 2010, 7:28 am
The other side first argued, after Wyeth v. [read post]
29 Jan 2010, 6:15 am
Wyeth-Ayerst Labs., 385 F.3d 961, 965-66 (6th Cir. 2004). [read post]
27 Jan 2010, 9:20 pm
[Korris, WV Record; cross-posted from Point of Law; typo now fixed] Tags: pharmaceuticals, sanctions Related posts Wyeth v. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
25 Jan 2010, 5:00 am
As we said last week, because it’s a Dechert case, we can’t comment directly on Clark v. [read post]
21 Jan 2010, 1:00 am
(Patent Docs) Faslodex (Fulvestrant) - US: Infringement of US Patent following a Paragraph IV certification: AstraZeneca Pharmaceuticals LP et al. v. [read post]
14 Jan 2010, 11:08 pm
A dozen companies that sold the drugs are named in the Arkansas suits, including Pfizer Inc. and Wyeth Pharmaceuticals Inc., Barr Laboratories Inc. and Mead Johnson & Co., among others. [read post]
13 Jan 2010, 3:00 am
(IP Factor) Netherlands: Court of Appeal, The Hague: Costs of procedure : Lundbeck v Tiefenbacher, Centrafarm Services and Ratiopharm (EPLAW) Poland: First judgment on differences between sponsorship and advertising of pharmaceutical product (Class 46) US: USPTO to begin recalculating patent term following Wyeth v Kappos (Patently-O) (Patent Docs) US: CAFC confirms PTO is miscalculating (undercalculating) delays in prosecution and the corresponding patent term adjustment:… [read post]
12 Jan 2010, 2:47 pm
At the crux of this dispute between Wyeth Pharmaceuticals and the USPTO is a process for calculating the amount that a patent term is adjusted under the American Inventors Protection Act, 35 U.S.C. 154(b). [read post]
11 Jan 2010, 6:00 am
KV Pharmaceutical Co., No. 4:09CV00588SNLJ, slip op. [read post]
8 Jan 2010, 9:59 am
In a much anticipated decision, the Federal Circuit held yesterday that two pharmaceutical companies, Wyeth and Elan Pharma, were entitled to extended patent term adjustments because the U.S. [read post]
7 Jan 2010, 10:36 am
Wyeth, 344 F. [read post]
5 Jan 2010, 5:37 am
Wyeth Pharmaceuticals, et al. that the trial judges grant of judgment notwithstanding the verdict in 2007 was erroneous. [read post]
4 Jan 2010, 1:50 pm
46 Indiana women are planning to sue the pharmaceutical company Wyeth (“Wyeth”) alleging that it sold its Prempro menopause medication without first warning the public that the medication can cause breast cancer. [read post]
31 Dec 2009, 7:19 am
In addition, the FTC approved two major mergers in the pharmaceutical industry. [read post]
30 Dec 2009, 6:27 pm
Wyeth, 25 No. 11 Andrews Pharmaceutical Litig. [read post]
28 Dec 2009, 7:41 am
Wyeth Pharmaceuticals Inc., 2009 BCCA 592 (available here) is an important contribution to the developing Canadian jurisprudence on the Civil Jurisdiction and Proceedings Transfer Act, a statute governing the taking of jurisdiction that has been adopted in several provinces. [read post]
25 Dec 2009, 11:02 pm
Wyeth Pharmaceuticals Inc., 040602368, Court of Common Pleas, Philadelphia County, Pennsylvania. [read post]
24 Dec 2009, 11:32 am
Wyeth, Inc., 561 F.3d 233 (3d Cir. 2009). [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow generic companies… [read post]
